SK882003A3 - 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use - Google Patents
16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use Download PDFInfo
- Publication number
- SK882003A3 SK882003A3 SK88-2003A SK882003A SK882003A3 SK 882003 A3 SK882003 A3 SK 882003A3 SK 882003 A SK882003 A SK 882003A SK 882003 A3 SK882003 A3 SK 882003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- substituted
- ethyl acetate
- compounds
- substituted steroid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00202697 | 2000-07-28 | ||
PCT/EP2001/008535 WO2002010188A1 (en) | 2000-07-28 | 2001-07-23 | 16alpha-methyl or ethyl substituted estrogens |
Publications (1)
Publication Number | Publication Date |
---|---|
SK882003A3 true SK882003A3 (en) | 2003-07-01 |
Family
ID=8171866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK88-2003A SK882003A3 (en) | 2000-07-28 | 2001-07-23 | 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use |
Country Status (25)
Country | Link |
---|---|
US (2) | US7696190B2 (cs) |
EP (1) | EP1307471B1 (cs) |
JP (1) | JP2004505093A (cs) |
KR (1) | KR20030029640A (cs) |
CN (1) | CN1220696C (cs) |
AR (1) | AR029989A1 (cs) |
AT (1) | ATE294812T1 (cs) |
AU (2) | AU8201601A (cs) |
BR (1) | BR0112791A (cs) |
CA (1) | CA2416311C (cs) |
CZ (1) | CZ2003270A3 (cs) |
DE (1) | DE60110606T2 (cs) |
EC (1) | ECSP034448A (cs) |
ES (1) | ES2241854T3 (cs) |
HR (1) | HRP20030060A2 (cs) |
HU (1) | HUP0301592A2 (cs) |
IL (2) | IL153934A0 (cs) |
IS (1) | IS6692A (cs) |
MX (1) | MXPA03000845A (cs) |
NO (1) | NO20030419L (cs) |
PE (1) | PE20020331A1 (cs) |
PL (1) | PL366235A1 (cs) |
SK (1) | SK882003A3 (cs) |
WO (1) | WO2002010188A1 (cs) |
ZA (1) | ZA200300417B (cs) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2305105C2 (ru) * | 2002-01-21 | 2007-08-27 | Н.В.Органон | СПОСОБ ПОЛУЧЕНИЯ 7α-МЕТИЛСТЕРОИДОВ, СОЕДИНЕНИЕ |
DE10213371C1 (de) * | 2002-03-21 | 2003-12-24 | Schering Ag | Verfahren zur Herstellung von 7alpha-Methylsteroiden |
UA89964C2 (ru) * | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
CN101014610B (zh) * | 2004-09-08 | 2012-08-22 | Msd欧斯股份有限公司 | 具有选择性雌激素活性的15β-取代的类固醇 |
CN114409717B (zh) * | 2021-12-17 | 2023-03-17 | 湖南科益新生物医药有限公司 | 替勃龙中间体醚化物和替勃龙的制备方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL226738A (cs) * | 1957-04-11 | |||
DE1084261B (de) * | 1957-04-11 | 1960-06-30 | Syntex Sa | Verfahren zur Herstellung neuer Cyclopentanophenanthrenderivate |
US3257429A (en) * | 1957-11-12 | 1966-06-21 | Syntex Corp | 16-methylene derivatives of estrone and estradiol |
US3007946A (en) * | 1958-11-06 | 1961-11-07 | Searle & Co | 3-alkoxy-16-methylene-1, 3, 5(10)-estratrien-17-ones |
US3049555A (en) * | 1959-12-22 | 1962-08-14 | Searle & Co | 3-alkoxy-16-methyl-1, 3, 5 (10)-estratrien-17-ones |
US3092645A (en) * | 1961-12-28 | 1963-06-04 | Searle & Co | Esters of 17alpha-alkynylester-5(10)-ene-3beta, 17beta-diols |
GB1110792A (en) * | 1964-04-07 | 1968-04-24 | Res Inst Medicine Chem | Novel 5(10)-dehydro-steroids |
US3299108A (en) * | 1965-10-18 | 1967-01-17 | Searle & Co | 17alpha-alkynyl/alkenyl-13beta-alkyl-11-alkylgona-1, 3, 5 (10)-triene-3, 17beta-diols, ethers and esters thereof and intermediates thereto |
US3465010A (en) * | 1966-11-22 | 1969-09-02 | Searle & Co | 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof |
US3377366A (en) * | 1966-12-02 | 1968-04-09 | Searle & Co | 17alpha-alkynyl/alkenyl-11, 13beta-dialkylgon-5(10)-en-3-ones and esters thereof |
ZA712312B (en) | 1970-04-28 | 1972-01-26 | Ochsner Med Found Alton | 4,14-estradiene compounds |
US3652606A (en) * | 1970-08-07 | 1972-03-28 | Searle & Co | 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof |
US3704253A (en) * | 1970-09-23 | 1972-11-28 | American Home Prod | 13 - polycarbonalkyl - 16 - methylgona-1,3,5(10)-trienes and 13-polycarbonalkyl-16-methylgon - 4 - en-3-ones and intermediates for their production |
FR2377419A1 (fr) * | 1977-01-13 | 1978-08-11 | Roussel Uclaf | Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament |
DE2757157C3 (de) | 1977-12-19 | 1980-10-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 16 a -alkylierten Steroiden |
AU572589B2 (en) | 1983-12-14 | 1988-05-12 | Upjohn Company, The | 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids |
US5116830A (en) * | 1984-08-17 | 1992-05-26 | Sri International | Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses |
DE3822770A1 (de) * | 1988-07-01 | 1990-01-04 | Schering Ag | 13-alkyl-11ss-phenylgonane |
ZA94715B (en) | 1993-02-08 | 1994-10-24 | Akzo Nv | Steroids for treating menopausal complaints |
CA2116829C (en) | 1993-03-05 | 2004-09-14 | Godefridus Hermanus Johanna Deckers | Use of a pregnane derivative |
KR20010041698A (ko) | 1998-03-09 | 2001-05-25 | 악조 노벨 엔.브이. | 신규 피임 키트 |
CA2333985C (en) * | 1998-06-19 | 2007-04-10 | Dirk Leysen | Testosterone derivative |
ATE222922T1 (de) | 1998-11-20 | 2002-09-15 | Akzo Nobel Nv | Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11 |
TW548277B (en) * | 1999-07-16 | 2003-08-21 | Akzo Nobel Nv | Orally active androgens |
PL353826A1 (en) * | 1999-09-06 | 2003-12-01 | Akzo Nobel N.V.Akzo Nobel N.V. | Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
-
2001
- 2001-07-23 JP JP2002515917A patent/JP2004505093A/ja not_active Withdrawn
- 2001-07-23 US US10/343,293 patent/US7696190B2/en not_active Expired - Fee Related
- 2001-07-23 DE DE60110606T patent/DE60110606T2/de not_active Expired - Lifetime
- 2001-07-23 AU AU8201601A patent/AU8201601A/xx active Pending
- 2001-07-23 CN CNB018133983A patent/CN1220696C/zh not_active Expired - Fee Related
- 2001-07-23 EP EP01960546A patent/EP1307471B1/en not_active Expired - Lifetime
- 2001-07-23 PL PL01366235A patent/PL366235A1/xx unknown
- 2001-07-23 CZ CZ2003270A patent/CZ2003270A3/cs unknown
- 2001-07-23 BR BR0112791-8A patent/BR0112791A/pt not_active IP Right Cessation
- 2001-07-23 IL IL15393401A patent/IL153934A0/xx active IP Right Grant
- 2001-07-23 KR KR10-2003-7001186A patent/KR20030029640A/ko not_active Application Discontinuation
- 2001-07-23 CA CA002416311A patent/CA2416311C/en not_active Expired - Fee Related
- 2001-07-23 HU HU0301592A patent/HUP0301592A2/hu unknown
- 2001-07-23 SK SK88-2003A patent/SK882003A3/sk unknown
- 2001-07-23 WO PCT/EP2001/008535 patent/WO2002010188A1/en active IP Right Grant
- 2001-07-23 AT AT01960546T patent/ATE294812T1/de not_active IP Right Cessation
- 2001-07-23 AU AU2001282016A patent/AU2001282016B2/en not_active Ceased
- 2001-07-23 MX MXPA03000845A patent/MXPA03000845A/es active IP Right Grant
- 2001-07-23 ES ES01960546T patent/ES2241854T3/es not_active Expired - Lifetime
- 2001-07-25 PE PE2001000751A patent/PE20020331A1/es not_active Application Discontinuation
- 2001-07-26 AR ARP010103558A patent/AR029989A1/es unknown
-
2003
- 2003-01-14 IL IL153934A patent/IL153934A/en not_active IP Right Cessation
- 2003-01-15 ZA ZA200300417A patent/ZA200300417B/xx unknown
- 2003-01-20 IS IS6692A patent/IS6692A/is unknown
- 2003-01-24 EC EC2003004448A patent/ECSP034448A/es unknown
- 2003-01-27 NO NO20030419A patent/NO20030419L/no not_active Application Discontinuation
- 2003-01-28 HR HR20030060A patent/HRP20030060A2/hr not_active Application Discontinuation
-
2009
- 2009-05-29 US US12/475,096 patent/US20100029603A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2416311C (en) | 2009-04-28 |
AU8201601A (en) | 2002-02-13 |
CN1444596A (zh) | 2003-09-24 |
KR20030029640A (ko) | 2003-04-14 |
ATE294812T1 (de) | 2005-05-15 |
IL153934A (en) | 2007-07-24 |
MXPA03000845A (es) | 2004-04-05 |
HRP20030060A2 (en) | 2004-06-30 |
NO20030419D0 (no) | 2003-01-27 |
JP2004505093A (ja) | 2004-02-19 |
CN1220696C (zh) | 2005-09-28 |
DE60110606D1 (de) | 2005-06-09 |
CA2416311A1 (en) | 2002-02-07 |
US7696190B2 (en) | 2010-04-13 |
EP1307471A1 (en) | 2003-05-07 |
CZ2003270A3 (cs) | 2003-06-18 |
PE20020331A1 (es) | 2002-04-30 |
NO20030419L (no) | 2003-01-27 |
US20040043976A1 (en) | 2004-03-04 |
DE60110606T2 (de) | 2005-12-01 |
ES2241854T3 (es) | 2005-11-01 |
AU2001282016B2 (en) | 2005-11-10 |
IL153934A0 (en) | 2003-07-31 |
BR0112791A (pt) | 2003-06-24 |
ECSP034448A (es) | 2003-03-10 |
IS6692A (is) | 2003-01-20 |
EP1307471B1 (en) | 2005-05-04 |
WO2002010188A1 (en) | 2002-02-07 |
HUP0301592A2 (hu) | 2003-09-29 |
PL366235A1 (en) | 2005-01-24 |
US20100029603A1 (en) | 2010-02-04 |
AR029989A1 (es) | 2003-07-23 |
ZA200300417B (en) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2178899B1 (de) | 17beta-cyano-18a-homo-19-nor-androst-4-en-derivat, dessen verwendung und das derivat enthaltende arzneimittel | |
EA014325B1 (ru) | 18-метил-9-нор-17-прегн-4-ен-21,17-карболактоны, а также лекарственные препараты, которые их содержат | |
JP2000256390A (ja) | 性ステロイド活性を抑制するために用いるエストロゲン核誘導体の医薬組成物 | |
US20100029603A1 (en) | 16alpha-methyl or ethyl substituted estrogens | |
DE60025958T2 (de) | 14,15-beta-methylen substituierte androgene | |
EP2170925B1 (de) | 17ß-CYANO-19-NOR-ANDROST-4-EN-DERIVAT, DESSEN VERWENDUNG UND DAS DERIVAT ENTHALTENDE ARZNEIMITTEL | |
US6677329B1 (en) | Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 | |
KR19980071540A (ko) | 피임 및 항-골다공증 활성을 갖는 스테로이드 화합물 | |
AU2001282016A1 (en) | 16alpha-methyl or ethyl substituted estrogens | |
EP2238149B1 (de) | 19-nor-steroidderivate mit einer 15alpha, 16alpha-methylengruppe und einem gesättigten 17,17-spirolactonring, deren verwendung sowie diese derivate enthaltende arzneimittel | |
EP2238150B1 (de) | 15,16-METHYLEN-17-HYDROXY-19-NOR-21-CARBONSÄURE-STEROID y-LACTON-DERIVAT, DESSEN VERWENDUNG UND DAS DERIVAT ENTHALTENDE ARZNEIMITTEL | |
EP2238147B1 (de) | 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-derivat, dessen verwendung und das derivat enthaltende arzneimittel | |
RU2255090C2 (ru) | Стероидные соединения, способ селективной модификации, фармацевтическая композиция | |
WO2009083266A1 (de) | 17-hydroxy-19-nor-21-carbonsäure-steroid y-lacton-derivat, dessen verwendung und das derivat enthaltende arzneimittel | |
WO2009083267A2 (de) | Steroid-17,17-lactol-derivat, dessen verwendung und das derivat enthaltende arzneimittel | |
WO2009083270A1 (de) | 15,16-methylen-steroid-17,17-lactol-derivat, dessen verwendung und das derivat enthaltende arzneimittel | |
WO2010066349A1 (de) | Verwendung von 17beta-cyano-19-androst-4-en-derivaten zur herstellung eines arzneimittels in depot-form zur parenteralen anwendung sowie depot-arzneimittel enthaltend 17beta-cyano-19-androst-4-en-derivate zur parenteralen anwendung | |
WO2010066354A1 (de) | VERWENDUNG VON 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-EN-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS IN DEPOT-FORM ZUR PARENTERALEN ANWENDUNG SOWIE DEPOT-ARZNEIMITTEL ENTHALTEND 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-EN-DERIVATE ZUR PARENTERALEN ANWENDUNG | |
WO2010066355A1 (de) | VERWENDUNG VON 17β- CYANO-19-NOR-ANDROST-4-EN-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS IN DEPOT-FORM ZUR PARENTERALEN ANWENDUNG SOWIE DEPOT-ARZNEIMITTEL ENTHALTEND 17β-CYANO-19-NOR-ANDROST-4-EN-DERIVATE ZUR PARENTERALEN ANWENDUNG |